ASHLEY VRECENAK: Open Payments
NPI 1639496565 · LONGWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,621 in 73 payments from 16 companies in 2025. Trend: 2023 $571 · 2024 $1,642 · 2025 $1,621
Food & beverage: $1,521Education: $100
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $321 |
| ABBVIE INC. | 7 | $185 |
| Botanix SB Inc | 4 | $180 |
| PFIZER INC. | 14 | $178 |
| Novartis Pharmaceuticals Corporation | 10 | $164 |
| UCB, Inc. | 6 | $121 |
| GENZYME CORPORATION | 4 | $102 |
| Incyte Corporation | 5 | $94 |
| E.R. Squibb & Sons, L.L.C. | 3 | $67 |
| LEO Pharma Inc. | 2 | $51 |
Products named: SOFDRA, CIBINQO, SKYRIZI, ILUMYA, Bimzelx, DUPIXENT, OPZELURA, COSENTYX.
Industry payments across FL — which companies pay providers there.
